InvestorsHub Logo
Followers 8
Posts 158
Boards Moderated 0
Alias Born 09/14/2014

Re: None

Monday, 10/06/2014 10:12:53 AM

Monday, October 06, 2014 10:12:53 AM

Post# of 6742
TKMR also has FDDA APPPROVAL---today overruling is just scared investors running for the exits...it should recover to the $26 rnage
MARKETS More: Ebola Virus Biotech
Ebola Drug Firm Tekmira Is Surging Again


Colorized scanning electron micrograph of filamentous Ebola virus particles (green) attached and budding from a chronically infected VERO E6 cell (orange) (25,000x magnification).

Shares of Tekmira Pharmaceuticals were up more than 14% on Monday after the company announced that it reached a "regulatory framework" with the FDA for using its TKM-Ebola treatment to treat Ebola.

In a press release, Tekmira said:

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced that the FDA has authorized Tekmira to provide TKM-Ebola for treatment



Read more: http://www.businessinsider.com/tekmira-reaches-fda-agreement-on-ebola-treatment-2014-9#ixzz3FNFyTfYb
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News